- Home
- ERAS vs LTBR Comparison
ERAS vs LTBR Comparison
Compare ERAS & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERAS
- LTBR
- Stock Information
- Founded
- ERAS 2018
- LTBR 1992
- Country
- ERAS United States
- LTBR United States
- Employees
- ERAS N/A
- LTBR N/A
- Industry
- ERAS Biotechnology: Pharmaceutical Preparations
- LTBR Professional Services
- Sector
- ERAS Health Care
- LTBR Consumer Discretionary
- Exchange
- ERAS Nasdaq
- LTBR Nasdaq
- Market Cap
- ERAS 439.7M
- LTBR 397.8M
- IPO Year
- ERAS 2021
- LTBR N/A
- Fundamental
- Price
- ERAS $1.71
- LTBR $15.16
- Analyst Decision
- ERAS Buy
- LTBR
- Analyst Count
- ERAS 6
- LTBR 0
- Target Price
- ERAS $3.83
- LTBR N/A
- AVG Volume (30 Days)
- ERAS 964.1K
- LTBR 1.2M
- Earning Date
- ERAS 11-11-2025
- LTBR 10-30-2025
- Dividend Yield
- ERAS N/A
- LTBR N/A
- EPS Growth
- ERAS N/A
- LTBR N/A
- EPS
- ERAS N/A
- LTBR N/A
- Revenue
- ERAS N/A
- LTBR N/A
- Revenue This Year
- ERAS N/A
- LTBR N/A
- Revenue Next Year
- ERAS N/A
- LTBR N/A
- P/E Ratio
- ERAS N/A
- LTBR N/A
- Revenue Growth
- ERAS N/A
- LTBR N/A
- 52 Week Low
- ERAS $1.01
- LTBR $2.36
- 52 Week High
- ERAS $3.31
- LTBR $18.80
- Technical
- Relative Strength Index (RSI)
- ERAS 59.36
- LTBR 53.97
- Support Level
- ERAS $1.53
- LTBR $13.83
- Resistance Level
- ERAS $1.69
- LTBR $14.96
- Average True Range (ATR)
- ERAS 0.10
- LTBR 0.96
- MACD
- ERAS 0.01
- LTBR -0.00
- Stochastic Oscillator
- ERAS 96.20
- LTBR 60.38
About ERAS Erasca Inc.
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's product pipeline includes; Naporafenib, a pan-RAF inhibitor with first-in-class potential in NRASm melanoma, RAS Q61X tissue agnostic solid tumors, and other RAS/MAPK pathway-driven tumors, and ERAS-007 (oral ERK1/2 inhibitor) and ERAS-601 (oral SHP2 inhibitor), which target downstream and upstream nodes, respectively, of the RAS/MAPK pathway.
About LTBR Lightbridge Corporation
Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.